
Lymphoedema management – Access to a lymphoedema therapist
Patients who have been treated for breast cancer who develop lymphoedema should have access to a lymphoedema therapist.
How this guidance was developed
This recommendation was adapted from the NICE 2018 guidelines (UK). The source recommendation was based on a systematic review of the evidence conducted in July 2008 and used wording (‘Ensure’) indicative of a strong recommendation (using SIGN methods) by the source guideline authors. The recommendation was adapted by removing the word ‘rapid’ as rapid access is not always feasible, and by using language applicable to the Australian health care context.
Lymphoedema management – Access to a lymphoedema therapist
Patients who have been treated for breast cancer who develop lymphoedema should have access to a lymphoedema therapist.


This recommendation was adapted from the NICE 2018 guidelines (UK). The source recommendation was based on a systematic review of the evidence conducted in July 2008 and used wording (‘Ensure’) indicative of a strong recommendation (using SIGN methods) by the source guideline authors. The recommendation was adapted by removing the word ‘rapid’ as rapid access is not always feasible, and by using language applicable to the Australian health care context.